HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meng Wu Selected Research

Urinary Bladder Neoplasms (Bladder Cancer)

1/2022Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer.
1/2022Ferroptosis-Related Long Noncoding RNAs Have Excellent Predictive Ability for Multiomic Characteristics of Bladder Cancer.
1/2021Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer.
6/2020Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of VEGFR2-targeted CD-TK-loaded cationic nanobubbles in the treatment of bladder cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meng Wu Research Topics

Disease

115Neoplasms (Cancer)
06/2024 - 05/2012
21Inflammation (Inflammations)
05/2024 - 09/2012
18Infections
02/2023 - 10/2009
13COVID-19
01/2024 - 01/2020
12Prostatic Neoplasms (Prostate Cancer)
02/2024 - 12/2016
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 04/2015
10Neoplasm Metastasis (Metastasis)
01/2024 - 01/2019
10Fibrosis (Cirrhosis)
09/2023 - 11/2016
9Hepatocellular Carcinoma (Hepatoma)
09/2023 - 01/2008
9Lung Neoplasms (Lung Cancer)
01/2023 - 09/2009
8Ovarian Neoplasms (Ovarian Cancer)
10/2023 - 07/2016
8Ankylosing Spondylitis
03/2020 - 11/2017
7Melanoma (Melanoma, Malignant)
02/2024 - 01/2019
7Breast Neoplasms (Breast Cancer)
01/2024 - 01/2019
7Carcinoma (Carcinomatosis)
12/2023 - 01/2015
7Carcinogenesis
01/2023 - 03/2006
6Hypoxia (Hypoxemia)
02/2024 - 01/2017
6Lymphoma (Lymphomas)
12/2023 - 08/2014
6Wounds and Injuries (Trauma)
04/2023 - 08/2014
6Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2015
5Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2024 - 01/2018
5Gestational Diabetes (Gestational Diabetes Mellitus)
05/2023 - 01/2019
5Infertility (Sterility)
10/2022 - 01/2015
5Necrosis
12/2021 - 10/2014
4Bites and Stings (Sting)
05/2024 - 01/2020
4Colitis
05/2024 - 12/2012
4Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2024 - 05/2015
4Pain (Aches)
01/2024 - 01/2021
4Alzheimer Disease (Alzheimer's Disease)
12/2023 - 01/2022
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2023 - 01/2019
4Hemorrhage
05/2023 - 10/2020
4Type 2 Diabetes Mellitus (MODY)
05/2023 - 06/2018
4Chronic Obstructive Pulmonary Disease (COPD)
01/2023 - 11/2017
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 06/2020
4Rheumatoid Arthritis
09/2019 - 09/2012
3Hodgkin Disease (Hodgkin's Disease)
03/2024 - 12/2019
3Nasopharyngeal Carcinoma
01/2024 - 01/2023
3Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 07/2018
3Poisoning
09/2023 - 01/2023
3Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2023 - 01/2021
3Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 07/2013
3Hypertension (High Blood Pressure)
01/2023 - 07/2013
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2023 - 01/2020
3Reperfusion Injury
01/2023 - 01/2021
3Mouth Neoplasms (Oral Cancer)
09/2022 - 07/2019
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

37Proteins (Proteins, Gene)FDA Link
05/2024 - 08/2010
17Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2009
12CytokinesIBA
02/2024 - 09/2012
11RNA (Ribonucleic Acid)IBA
01/2024 - 07/2019
10Therapeutic UsesIBA
06/2024 - 09/2012
9DNA (Deoxyribonucleic Acid)IBA
12/2023 - 01/2013
8Messenger RNA (mRNA)IBA
02/2024 - 09/2009
7Immune Checkpoint InhibitorsIBA
01/2024 - 01/2019
7AntibodiesIBA
08/2023 - 09/2018
7Glucose (Dextrose)FDA LinkGeneric
05/2023 - 10/2013
7LigandsIBA
01/2023 - 01/2015
7MicroRNAs (MicroRNA)IBA
01/2021 - 06/2017
6Long Noncoding RNAIBA
01/2023 - 01/2019
5ArsenicIBA
05/2024 - 12/2022
5AlbuminsIBA
01/2024 - 01/2017
5IronIBA
05/2023 - 05/2017
5Hemoglobins (Hemoglobin)IBA
04/2023 - 01/2017
5Antiviral Agents (Antivirals)IBA
01/2023 - 09/2008
4Small Interfering RNA (siRNA)IBA
06/2024 - 11/2018
4arseniteIBA
05/2024 - 12/2022
4Androgen Receptors (Androgen Receptor)IBA
02/2024 - 01/2018
46-methyladenineIBA
01/2024 - 01/2021
4MethyltransferasesIBA
12/2023 - 01/2013
4Interferon Type IIBA
12/2023 - 01/2020
4EnzymesIBA
12/2023 - 01/2013
4Interleukin-17 (Interleukin 17)IBA
01/2023 - 01/2019
4Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2016
4AntigensIBA
01/2021 - 01/2016
4tylophorineIBA
09/2014 - 09/2012
3InterferonsIBA
05/2024 - 01/2023
3camrelizumabIBA
03/2024 - 01/2022
3Analgesics (Analgesic Drugs)IBA
01/2024 - 01/2021
31-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2023 - 06/2021
3Neutralizing AntibodiesIBA
07/2023 - 07/2020
3HydrogelsIBA
04/2023 - 01/2020
3Complement System Proteins (Complement)IBA
02/2023 - 01/2018
3ChemokinesIBA
01/2023 - 01/2020
3PlatinumIBA
01/2023 - 03/2016
3Fibrinogen (Factor I)FDA Link
09/2022 - 10/2015
3Interleukin-6 (Interleukin 6)IBA
09/2022 - 09/2018

Therapy/Procedure

45Therapeutics
06/2024 - 03/2010
30Immunotherapy
05/2024 - 09/2015
17Radiotherapy
05/2024 - 01/2015
16Drug Therapy (Chemotherapy)
12/2023 - 08/2014
6Precision Medicine
01/2021 - 01/2017
5Aftercare (After-Treatment)
10/2022 - 08/2014
5Photothermal Therapy
12/2021 - 01/2019
4Neoadjuvant Therapy
01/2024 - 01/2021
4Hematopoietic Stem Cell Transplantation
11/2023 - 01/2020
4Lasers (Laser)
01/2021 - 01/2018
3Castration
02/2024 - 01/2022
3Electroacupuncture
12/2023 - 01/2023
3Photochemotherapy (Photodynamic Therapy)
04/2023 - 06/2021
3Sutures (Suture)
01/2022 - 08/2014